Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2020 Filed May 19, 2020 21:04 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 9,715 | $66.05 | $641,675.75 |
DisclosureSEC source: 0001127602-20-017220 · form4.xml · nonDerivative · entry 3 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204,753 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.39 to $66.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 15, 2020 Filed May 19, 2020 21:04 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 5,442 | $64.96 | $353,512.32 |
DisclosureSEC source: 0001127602-20-017220 · form4.xml · nonDerivative · entry 2 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,214,468 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.35 to $65.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 15, 2020 Filed May 19, 2020 21:04 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 2,600 | $63.80 | $165,880.00 |
DisclosureSEC source: 0001127602-20-017220 · form4.xml · nonDerivative · entry 1 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219,910 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:55 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 700 | $66.90 | $46,830.00 |
DisclosureSEC source: 0001127602-20-017206 · form4.xml · nonDerivative · entry 5 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 596,500 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.60 to $67.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:55 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 5,809 | $66.11 | $384,032.99 |
DisclosureSEC source: 0001127602-20-017206 · form4.xml · nonDerivative · entry 4 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 597,200 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.59 to $66.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:55 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,937 | $65.06 | $191,081.22 |
DisclosureSEC source: 0001127602-20-017206 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 603,009 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.54 to $65.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:55 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 1,600 | $63.91 | $102,256.00 |
DisclosureSEC source: 0001127602-20-017206 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 605,946 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.50 to $64.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: These shares are owned directly by a trust for the benefit of Mr. Bancel's children and of which the trustee is an independent institution. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:55 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
GiftCommon Stock | 1,577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-017206 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,739,044 F1 · kind: The reported disposition was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| May 15, 2020 Filed Jun 4, 2020 22:33 UTC Amendment |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 2,600 | $63.80 | $165,880.00 |
DisclosureSEC source: 0001127602-20-018892 · form4a.xml · nonDerivative · entry 1 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219,910 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on September 18, 2019. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 15, 2020 Filed Jun 4, 2020 22:22 UTC Amendment |
Bancel StephaneDirector · Chief Executive Officer
|
GiftCommon Stock | 1,577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-018886 · form4a.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,739,044 F1 · kind: The reported disposition was effected pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2019. F2 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 700 | $66.26 | $46,382.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 10 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,006,540 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.96 to $66.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,700 | $64.46 | $109,582.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 9 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007,240 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.43 to $65.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,674 | $65.28 | $109,278.72 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,008,940 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.84 to $65.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 726 | $62.94 | $45,694.44 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,010,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.78 to $64.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 200 | $60.77 | $12,154.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 6 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011,340 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.71 to $60.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 127,500 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · derivative · entry 9 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,822 Underlying: Common Stock · 127,500 shares Expires 2027-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 1,300 | $66.89 | $86,957.00 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 8 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.88 to $66.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 15,640 | $66.27 | $1,036,462.80 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 7 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.85 to $66.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 46,517 | $65.28 | $3,036,629.76 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 6 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,940 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.84 to $65.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 38,089 | $64.44 | $2,454,455.16 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 5 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,457 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.83 to $64.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 16,183 | $63.17 | $1,022,280.11 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 4 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,546 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.80 to $63.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 8,371 | $62.41 | $522,434.11 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 3 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,729 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.78 to $62.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 1,400 | $61.16 | $85,624.00 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 2 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,100 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.75 to $61.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:02 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 127,500 | $12.21 | $1,556,775.00 |
DisclosureSEC source: 0001127602-20-016625 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 13, 2020 Filed Jun 4, 2020 22:41 UTC Amendment |
Andres JuanSee remarks
|
SaleCommon Stock | 1,300 | $66.89 | $86,957.00 |
DisclosureSEC source: 0001127602-20-018895 · form4a.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.88 to $66.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 12, 2020 23:17 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
OtherCommon Stock | 55,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016322 · form4.xml · nonDerivative · entry 11 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,740,621 F13 · kind: Represents the receipt of shares by the reporting person pursuant to pro rata distributions-in-kind, without consideration, of shares of the Company's common stock effected on May 12, 2020 by Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") to the partners of Flagship Fund IV and by its general partner, Flagship Ventures Fund IV General Partner, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 100 | $66.69 | $6,669.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011,540 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 735 | $65.80 | $48,363.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011,640 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.65 to $66.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 2,382 | $64.82 | $154,401.24 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,012,375 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.56 to $65.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 900 | $64.16 | $57,744.00 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014,757 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.51 to $64.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:34 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 883 | $62.68 | $55,346.44 |
DisclosureSEC source: 0001127602-20-016656 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.25 to $63.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 125,044 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · derivative · entry 8 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,442 Underlying: Common Stock · 125,044 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 17,744 | $62.65 | $1,111,661.60 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 7 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.09 to $63.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 19,817 | $63.59 | $1,260,163.03 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 6 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,744 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.10 to $64.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 59,913 | $64.72 | $3,877,569.36 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 5 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,561 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.11 to $65.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 25,905 | $65.46 | $1,695,741.30 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 4 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,474 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.12 to $66.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 1,365 | $66.43 | $90,676.95 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 3 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,379 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.13 to $67.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
SaleCommon Stock | 300 | $67.23 | $20,169.00 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 2 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,744 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.16 to $67.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:56 UTC |
Zaks Tal ZviChief Medical Officer
|
Exercise / conversionCommon Stock | 125,044 | $12.21 | $1,526,787.24 |
DisclosureSEC source: 0001127602-20-016613 · form4.xml · nonDerivative · entry 1 Zaks Tal Zvi · CIK 0001690927 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,643 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · derivative · entry 10 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,522 Underlying: Common Stock · 11,643 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F9 · derivative.exercise_date: 25% of this option vested and became exercisable on February 22, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 229,357 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · derivative · entry 9 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 229,357 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 2,237 | $67.32 | $150,594.84 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 8 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,510 F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.16 to $67.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 5,677 | $66.43 | $377,123.11 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 7 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,224,747 F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.12 to $66.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 61,412 | $65.47 | $4,020,643.64 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 6 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,424 F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.10 to $66.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 104,544 | $64.67 | $6,760,860.48 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 5 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291,836 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.09 to $65.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 31,948 | $63.57 | $2,030,934.36 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 4 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,380 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.07 to $64.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
SaleCommon Stock | 35,182 | $62.56 | $2,200,985.92 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 3 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,328 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.04 to $63.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
Exercise / conversionCommon Stock | 229,357 | $10.90 | $2,499,991.30 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 2 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:00 UTC |
Kim Lorence H.Chief Financial Officer
|
Exercise / conversionCommon Stock | 11,643 | $12.21 | $142,161.03 |
DisclosureSEC source: 0001127602-20-016619 · form4.xml · nonDerivative · entry 1 Kim Lorence H. · CIK 0001643746 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:53 UTC |
NABEL ELIZABETH GDirector
|
SaleCommon Stock | 30,000 | $66.00 | $1,980,000.00 |
DisclosureSEC source: 0001127602-20-016607 · form4.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,344 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.